BGF World Healthscience vs UBS Lux Equity Fund Biotech USD

BGF World Healthscience vs UBS Lux Equity Fund Biotech USD

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in BGF World Healthscience and UBS Lux Equity Fund Biotech USD.

BGF World Healthscience UBS Lux Equity Fund Biotech USD
1. UnitedHealth Group Inc
USA
8.2 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Eli Lilly and Co
USA
7.01 %
2. Moderna Inc
9.21 %
3. Novo Nordisk B
Denmark
6.67 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Merck & Co Inc
Germany
3.99 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Boston Scientific Corp
3.67 %
5. AbbVie Inc
USA
4.91 %
6. AbbVie Inc
USA
3.61 %
6. Gilead Sciences Inc
USA
4.66 %
7. Amgen Inc
USA
3.58 %
7. Amgen Inc
USA
4.43 %
8. Sanofi SA
France
3.05 %
8. BioNTech SE
4.13 %
9. Abbott Laboratories
USA
3.02 %
9. Karuna Therapeutics Inc
3.75 %
10. AstraZeneca
Sweden UK
2.98 %
-

The list of fund holdings was last updated on July 25, 2025.